SupCD7 CART for Relapsed or Refractory CD7 Positive Hematologic Malignancies

Clinical trial NCT07153068 · RECRUITING

Trial details

NCT number: NCT07153068
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

T Lymphoblastic Leukemia/Lymphoma Acute Myeloid Leukemia (AML)

Start date: 2025-06-28
Primary completion: 2028-06-28
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.